# Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation

> **NCT05164107** · NA · RECRUITING · sponsor: **Kardium Inc.** · enrollment: 175 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Globe Mapping and Pulsed Field Ablation System (Globe PF System)

## Key facts

- **NCT ID:** NCT05164107
- **Lead sponsor:** Kardium Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-08
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 175 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05164107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05164107, "Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05164107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*